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ONCOLOGY

Case Report: Uncontrolled Anasarca:
Capillary Leak Syndrome
Ankita Mehta, MD, and Mansi Shah, MD

INTRODUCTION
Capillary leak syndrome (CLS) is a rare clinical disease that
causes edema, hypoproteinemia, episodic hypotension,
dyspnea, hyponatremia, and weight gain that can be life
threatening 1. Although the underlying pathology is
currently unknown, CLS is thought to be secondary to a
systemic process associated with hyperpermeability of the
body's microcirculation, resulting from a diffuse and
severe disruption of the endothelium and causing
generalized edema and often acute respiratory distress2.

CASE PRESENTATION
A 60 year old female with metastatic pancreatic cancer
undergoing gemcitabine treatment presented with weight
gain, dyspnea on exertion, and orthopnea. Since the
initiation of gemcitabine three months prior to presentation,
the patient had noticed progressive weight gain - 5 lbs a
week, with the rate of weight gain accelerating recently.
This coincided with bilateral lower extremity swelling and
abdominal distension. On physical examination, the
patient had jugular venous distension and lower extremity
edema. Labs were significant for an albumin of 3.1 g/dL
with a normal hepatic panel, a sodium of 131 mmol/L, and
urine studies that were not consistent with nephrotic
range proteinuria. Imaging had nonspecific findings. Chest
X Ray demonstrated small bilateral pleural effusions and
an abdominal ultrasound revealed mild ascites. Ventricular
dysfunction and venous thromboses were excluded with
an echocardiogram and lower extremity ultrasound.
Ultimately, the anasarca was attributed to capillary leak
syndrome induced by gemcitabine therapy.

DIFFERENTIAL DIAGNOSIS
Prior to presuming capillary leak syndrome, it was
necessary to eliminate other causes of anasarca.
Echocardiogram was done to rule out cardiac dysfunction.
Urine studies indicated that a renal process causing
nephrotic syndrome was not the predominant disease
pathology. Abdominal ultrasound ruled out liver pathology.

OUTCOME AND FOLLOWUP
The patient was given diuretics and responded well over
the course of a few days. Her hyponatremia resolved and
she was sent home with an oral diuretic regimen. She was
asked to monitor daily weights with instructions to report
any changes of greater than 5 lbs to her doctor. Although
she continued to be anasarcic, her dyspnea improved.
Chemotherapy was discontinued, and the patient was
readmitted to the hospital within two months due to
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progression of her pancreatic cancer. She was ultimately
discharged home with hospice care.

DISCUSSION
Capillary leak syndrome (CLS) is a very rare (<1%) but
important and severe adverse effect of gemcitabine
therapy. There are some emerging case reports of
capillary leak syndrome secondary to treatments from
taxanes such as docetaxel and paclitaxel. As demonstrated
by this case, capillary leak syndrome is difficult to treat
with diuretics alone. Other reports recommend that there
may be a therapeutic effect from high dose corticosteroids
when given in conjunction with diuretics. Corticosteroid
prophylaxis given concurrently with gemcitabine therapy
may decrease toxicity that can curtail potentially fatal
outcomes.4 It will be important to determine if there is a
dose dependent relationship between gemcitabine and
CLS to ensure a safe medication profile.
Moreover, falling albumin levels along with weight gain in
patients receiving gemcitabine may be precursors to CLS,
and such patients should be screened for potential
respiratory symptoms. It is important to include capillary
leak syndrome in the differential in patients presenting
with anasarca not due to cardiac, renal, or hepatic causes
as it may lead to earlier cessation of gemcitabine treatment
and potentially improved outcomes.

KEY POINTS
Our patient on gemcitabine therapy presented with
anasarca, which was unexplained by specific organ failure,
and likely was the result of gemcitabine induced capillary
leak syndrome. Capillary leak syndrome is an uncommon
and poorly understood adverse effect of gemcitabine. More
research is required to understand how to effectively treat or
prevent this severe and potentially life threatening condition.
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